These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6322398)

  • 1. Ultrastructure of liver cell and bile duct carcinomas.
    Ordóñez NG; Mackay B
    Ultrastruct Pathol; 1983; 5(2-3):201-41. PubMed ID: 6322398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular and cholangiocellular carcinoma in a dog.
    Shiga A; Shirota K; Enomoto M
    J Vet Med Sci; 2001 Apr; 63(4):483-6. PubMed ID: 11346190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study.
    Ng IO; Shek TW; Nicholls J; Ma LT
    J Gastroenterol Hepatol; 1998 Jan; 13(1):34-40. PubMed ID: 9737569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appearance of hepatocytelike cells in the interlobular bile ducts of human liver in various liver disease states.
    Nomoto M; Uchikosi Y; Kajikazawa N; Tanaka Y; Asakura H
    Hepatology; 1992 Nov; 16(5):1199-205. PubMed ID: 1385291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor grading of the hepatobiliary system].
    Jütte H; Tannapfel A
    Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi?
    Peng N; Li L; Cai X; Tan S; Wu T
    Stem Cell Rev Rep; 2010 Dec; 6(4):579-84. PubMed ID: 20809255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant differentiation patterns in primary liver carcinoma.
    Sempoux C; Paradis V; Saxena R
    Semin Diagn Pathol; 2017 Mar; 34(2):176-182. PubMed ID: 28256363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
    Okuda K; Kubo Y; Okazaki N; Arishima T; Hashimoto M
    Cancer; 1977 Jan; 39(1):232-46. PubMed ID: 64293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of electron microscopy in diagnostic pathology. Case 7.
    Lapis K
    Ultrastruct Pathol; 1980; 1(1):105-9. PubMed ID: 6262962
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver.
    Tajima T; Honda H; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Taguchi K; Shimada M; Masuda K
    J Comput Assist Tomogr; 1999; 23(5):690-5. PubMed ID: 10524847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-needle aspiration cytology of pediatric patients with primary hepatic tumors: a comparative study of two hepatoblastomas and a liver-cell carcinoma.
    Dekmezian R; Sneige N; Popok S; Ordóñez NG
    Diagn Cytopathol; 1988; 4(2):162-8. PubMed ID: 2854046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrolamellar carcinoma as a cause of bile duct obstruction.
    Eckstein RP; Bambach CP; Stiel D; Roche J; Goodman BN
    Pathology; 1988 Oct; 20(4):326-31. PubMed ID: 2853861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particles observed in transplantable intrahepatic bile duct carcinomas and hepatoma of Syrian golden hamsters.
    Mori H; Hayashi K; Kato T; Hirono I
    Gan; 1973 Feb; 64(1):79-81. PubMed ID: 4352327
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologic diagnosis of hepatic tumors.
    Goodman ZD
    Ann Clin Lab Sci; 1984; 14(3):169-78. PubMed ID: 6329068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
    Riener MO; Fritzsche FR; Soll C; Pestalozzi BC; Probst-Hensch N; Clavien PA; Jochum W; Soltermann A; Moch H; Kristiansen G
    Histopathology; 2010 Apr; 56(5):600-6. PubMed ID: 20459570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepato-cholangiocarcinoma with diffuse metastases and hypercalcemia].
    Pérez Roldán F; Carretero L; Aguirre A; Bañares R; Casado M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1995 Oct; 87(10):743-7. PubMed ID: 8519543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma presenting as a tumour of the hilar and extrahepatic bile ducts.
    Thomsen GH; Kruse A; Petersen A
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):803-4. PubMed ID: 9831278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.
    Gil-Benso R; Martinez-Lorente A; Pellin-Perez A; Navarro-Fos S; Gregori-Romero MA; Carda C; Callaghan R; Peydro-Olaya A; Llombart-Bosch A
    In Vitro Cell Dev Biol Anim; 2001 Jan; 37(1):17-25. PubMed ID: 11249201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.